Skip to main content

06-07-2018 | Rheumatoid arthritis | Article

Biologic prescribing decisions following serious infection: Results from the British Society for Rheumatology Biologics Register—Rheumatoid Arthritis

Subesinghe S et al. Rheumatology (Oxford) 2018: key198. doi: 10.1093/rheumatology/key198

Please follow the link below to view this article in full on a third-party website. Note that a subscription or payment may be required.

Related topics